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Summary This study examined the effect of n-6 polyunsaturated fatty acids (PUFAs) on the expression of nm-23, a metastasis-suppressor
gene, in two highly invasive human cancer cell lines, HT1 15 and MDA MB 231. A range of n-6 and n-3 PUFAs were tested. We report that
while linoleic acid and arachidonic acid reduced the expression of nm-23-H1, gamma linolenic acid (GLA) and its soluble lithium salt markedly
increased the expression of the molecules. The stimulation of the expression of nm-23 by GLA was seen at both protein and mRNA levels.
Up-regulation of nm-23 was also associated with a reduction of the in vitro invasiveness of these cells. It is concluded that gamma linolenic
acid (GLA) enhances the expression of nm-23. This contributes to the inhibition of the in vitro invasion of tumour cells.
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nm-23 is a known metastasis-suppressor gene (Steeg et al, 1988;
Bevelacqua et al, 1989; Rosengard et al, 1989; for reviews see
Steeg et al, 1993; MacDonald et al, 1995; Rosa et al, 1995). Three
human nm-23 genes have been identified, designated nm-23-H1,
nm-23-H2 and DR-nm-23 (Venturelli et al, 1995). HI and H2
encode nucleoside diphosphate kinase (NDPK) A and NDPK B
polypeptides respectively. Both in vivo andinvitro, thenm-23 gene
and expression ofits protein product correlate with non-metastatic
behaviourofcancercells. In vitro, the motility andthe invasiveness
of tumour cells inversely correlate with the level ofnm-23; trans-
fection of highly invasive cells with nm-23 cDNA results in a
reduction orcompleteinhibition ofinvasiveness (Leone et al, 1991,
1993; Kantor et al, 1993). Conversely, experimental deletion ofthe
nm-23 gene results in a highly invasive cell phenotype. Recent
studies by Hsu et al (1995) have implicated nm-23 in theregulation
ofsignal transduction pathways usedby motility factors.
In both animal and clinical studies, nm-23 levels have been
found to be decreased in tumour cells and tissues, and this reduc-
tion has been shown tobe closely related to disease stage, presence
of metastases and prognosis. Reduction of nm-23 levels has been
observed in patients with colorectal cancer (Yamaguchi et al,
1993; Campo et al, 1994; Royds et al, 1994), breast cancer
(Hennessey et al, 1991; Tokunaga etal, 1993; Noguchi et al, 1994;
Simpson et al, 1994), liver cancer (Iizuka et al, 1995), melanoma
(Xerri et al, 1994), oesophageal cancer, bladder cancer (Fujii et al,
1995), ovarian cancer (Mandai et al, 1995; Viel et al, 1995) and
several other tumour types (Rosa et al, 1995). Interestingly,
however, this relationship is not seen inthyroid cancer(Holm etal,
1995). In the early stages of colorectal cancer, it seems that there
may be an overexpression of both nm-23-H1 and H2, but at
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advanced stages there is a marked reduction ofnm-23-H1 protein
(Martinez et al, 1995). Colorectal cancer may also be associated
with mutations of nm-23 (Wang et al, 1993). Missense mutations
and loss of heterozygosity of nm-23 have also been reported in
both ovarian serous carcinoma (Mandai et al, 1995) and primary
breast cancer (Cropp et al, 1994). In ovarian tumours, reduction of
nm-23 is related to the lymphatic dissemination of tumour cells
(Viel et al, 1995), and in breast cancer it has been suggested that
impairment of nm-23 is correlated with lymph node involvement
(Noguchi et al, 1994).
In a number of studies, some essential fatty acids have been
shown to be selectively toxic to tumour cells: among these are
gamma linolenic acid, a member of the n-6 series and eicosa-
pentaenoic acid, a member ofthe n-3 series ofessential fatty acids
(for areview see Horrobin, 1990). However another study failed to
show a clear pattern of the selectivity among normal and tumori-
genic cells (Maehle et al, 1995). These fatty acids have been tested
on a range of cancer cell types, including lung, breast, prostate,
pancreatic cancer and hepatoma cells (Begin et al, 1986, 1988;
Botha et al, 1989; Newman, 1990; Rose et al, 1991; Tiwari et al,
1991; Hayashi et al, 1992; Takeda et al, 1992, 1993). Furthermore,
the inhibition oftumour cell growth by certain cytokines is depen-
dent on the presence of polyunsaturated fatty acids (PUFAs)
(Newman, 1990). Lipid peroxides have been shown to be impor-
tant factors responsible for n-6 fatty acid-induced cytotoxicity
(Horrobin, 1990).
We have previously investigated the role of essential fatty acids
(EFAs) in the invasion and metastatic behaviour ofcancer cells and
have shown that certain EFAs, including gamma linolenic acid
(GLA), produce a marked inhibition of the motility/invasiveness
and metastatic properties ofcancer cells. These are effects that may
arise in part by the up-regulation of cell surface E-cadherin and
other related molecules (Jiang et al, 1995a and b). However, GLA
also inhibits the motility and in vitro invasiveness of tumour cells
that have been shown to be E-cadherinnegative (e.g. HT115 human
colon cancerandMDAMB 231 humanbreast cancercells)(Jiang et
al, 1995 a andb) and so othermechanisms must also be operative.
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These observations led us to look for other metastatic parame-
ters that might contribute to an explanation of the anti-invasion
effects exerted by these fatty acids. We report here that GLA, at
non-toxic concentrations, up-regulates the expression of nm-23-
HI in HT115 and MDA MB 231 cells. This regulation appears to
be at a transcriptional level, as both Western and Northern blotting
revealed increased protein and mRNA expression in response to
GLA treatment. This change in nm-23 levels correlates with a
reduction in the in vitro invasiveness ofthese cells.
MATERIALS AND METHODS
A human colon cancercell line, HT115, and a human breast cancer
cell line, MDA-MB-231, were obtained from the European
Collection of Animal Cell Culture (ECACC, Porton Down,
Salisbury, UK) and the ATCC (American Type Cell Collection,
Rockville, Maryland, USA) respectively. Cells were routinely
cultured with Dulbecco's modified Eagle medium (DMEM)
supplemented with 10% fetal calf serum (FCS).
Matrigel (reconstituted basement membrane) was purchased
from Collaborative Research Products (Bedford, Massachusetts,
USA). A transwell plate equipped with a porous insert (pore size
8.0 ,im) was from Becton Dickinson Labware (Oxford, UK) and
used forthe in vitro invasion study. A mouse anti-human nm-23-HI
monoclonal antibody was from Santa-Cruz Biotechnology
(Autogen Bioclear UK, Devizes, Wilts, UK). Peroxidase-
conjugated rabbit anti-mouse IgG for both immunohistochemical
studies and Western blotting was from Amersham International
(Little Chalfont, Buckinghamshire, UK). Recombinant human
hepatocyte growth factor/scatter factor (HGF/SF) was a generous
gift from Dr T Nakamura, Osaka, Japan. The cells were passaged
three to five times before assays were undertaken. Hoescht 33258,
gamma linolenic acid (GLA), linoleic acid (LA), arachidonic acid
(AA) and eicosapentaenoic acid (EPA) were from Sigma-Aldrich
(Poole, Dorset, UK). A water-soluble lithium saltofGLA was from
Callanish (Isle of Lewis, Scotland). All the fatty acids were
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dissolved in ethanol and stored in liquid nitrogen before use. Fatty
acids were diluted in culture medium with 10% FCS, with the final
concentration ofethanol being less than 0.01% (Jiang et al, 1995a).
A cDNA probe for human nm-23-HI was used for Northern blot-
ting studies and was obtained from ATCC (American Type Culture
Collection, Rockville, MD, USA). All other materials were
purchased from Sigma-Aldrich unless otherwise stated.
Cell invasion assay
This was based on the methods ofAlbini et al (1987) and Parish et
al (1992). Transwell chambers (Costar, Cambridge, MA, USA)
equipped with a 6.5-mm-diameter polycarbonate membrane (pore
size 8 ,um) were precoated with a solubilized tissue basement
membrane (Matrigel; 50 jig permembrane). After gel rehydration,
50 000 cells were added to each membrane with or without treat-
ment. Hepatocyte growth factor/scatter factor (20 ng ml-') was
used in the lowerchamberto induce invasion. After a 72-h culture,
the non-invasive cells were removed with a cotton swab and the
cells that had migrated through the membrane and stuck to the
lower surface were fixed and stained with crystal violet. After
extraction with 10% acetic acid, the absorbance was measured at
540 nm with a Titertek multiscanner.
SDS-PAGE and Western blotting
To test theeffects offatty acids on nm-23 expression, arange offive
fatty acids were used at 50 jiM (a concentration that we have previ-
ously shown to be non-toxic to these cells; Jiang et al, 1995a and b)
for 24 h. Cells were alsotreated with specific fatty acid at a range of
concentrations over various periods. After treatment with fatty
acids, cells were pelleted and lysed in HCMF buffer containing 1%
Triton, 0.1% sodium dodecyl sulphate (SDS), 2 mm calcium chlor-
ide, 100jig ml-1 phenylmethysulphonyl fluoride (PMSF), 1 jig ml-'
leupeptin and 1 jg ml-' aprotinin for 30 min. They were then boiled
at 100°C for 5 min before clarification at 13 000g for 10min.
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Figure 1 The effect of fatty acids on the expression of nm-23-H1 in HT1 15
cells (Western blotting). Fatty acids were used at 50gM and cultured with
cells for 24 h. Selective up-regulation of nm-23was seen with GLA and
LiGLA. AA, arachidonic acid; LiGLA, GLA lithium salt; LA, linoleic acid; EPA,
eicosapentaenoic acid. Top, nm23 protein probed with anti-nm23 antibody;
bottom, nm23 protein band volume obtained from densitometry
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Figure 2 Effect of fatty acids on the expression of nm-23-H1 in MDA MB
231 cells (Western blotting). Experimental conditions were as in Figure 1
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Figure 3 Immunocytochemical detection of nm-23 in HT1 15 (A and B) and MDA MB 231 (C and D) cells. A and C, control; B and D, cells treated with GLA at
50gM for 24 h. There was an increased intracellular staining of nm-23 after GLA treatment
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Figure 4 Concentration-dependent stimulation of nm-23 by GLA in HT1 15
cells by Western blotting. The treatment was for 24 h. The increased
expression was seen at concentrations over 10gM. Top, nm23 protein probed
with anti-nm23 antibody; bottom, nm23 protein band volume obtained from
densitometry
Protein concentrations were measured using fluorescamine and
quantified by using a multifluoroscanner (Denly, Sussex, UK).
Equal amounts of protein from each cell sample (30 ,g per lane)
(controls and treated) were added on to a 12% polyacrylamide gel.
After electrophoresis, proteins were blotted on to nitrocellulose
sheets and blocked in 10% skimmed milk for 60 min before probing
with the nm-23 antibody (1:1500) and a peroxidase-conjugated
secondary antibody (1:2000). A low-molecular-weight marker
mixture (SDS-7, Sigma) was used to determine the protein size.
Protein bands were visualized with an enhanced chemiluminescence
(ECL) system (Amersham International, UK). Protein band densi-
ties were measured with a laser densitometer and band volumes
were analysed with the Molecular Analyst software (Bio-Rad
Laboratories, Hemel Hempstead, Hertfordshire, UK).
Northern and slot blotting
Cells in 75-cm2 flasks were treated with fatty acids for4, 12, 24, 48
and 72 h or over a range offatty acid concentrations (1.0-150 ,UM)
for 24 h. Some cells were treated with different fatty acids at fixed
concentration for 24 h forcomparison between these differentfatty
acids. Total cellular RNA was extracted as previously described
(Chomczynski and Sacchi, 1987). For Northern analysis, 10 gg of
total RNA were resolved on a 0.8% denaturing agarose gel and
transferred to a nylon membrane. A cDNA probe for human nm-
23-H1 was used for subsequent hybridization overnight at 45°C in
the presence of formamide. Membranes were washed under strin-
gent conditions and then exposed to radiographic film. Slot blots
were also performed on the cellular RNA using a slot blotter
(Whatman, Maidstone, Kent, UK). All the blots were subsequently
re-probed with a human f-actin cDNA to correct for loading
errors. mRNA band densities of both nm-23 and actin were simi-
larly determined using laser densitometry, and nm-23 levels are
shown here as the ratio ofnm-23 in treated samples vs control. The
formula used to calculate these ratios is: (nm23 signal in treated
cells/nm23 signal in control)/(actin signal in treated cells/actin
signal in control).
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Figure 5 Concentration-dependent stimulation of nm-23 by GLA in MDA
MB 231 cells. The experimental conditions were as in Figure 4
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Figure 6 Time-related effects of GLA on the expression of nm-23 in MDA
MB 231 cells by Western blotting. GLA was used at 50 gM. An increased
protein level was seen 12 h after GLA treatment. Top, nm23 protein probed
with anti-nm23 antibody; bottom, nm23 protein band volume obtained from
densitometry
Immunohistochemical study
Cells were fixed with 4% formaldehyde and permeabilized with
0.01% Triton XlOO for 5 min before blocking with 10% milk for
60 min. Cells were then incubated with nm-23 monoclonal anti-
body for 60 min and extensively washed. After this, peroxidase-
conjugated secondary antibody was added and the colour
developed using diaminobenzidine (DAB, 180,g ml-' containing
0.03% hydrogen peroxide). Slides were mounted with slide
mountant Sterilyte (BDH) and photographed.
Cell growth monitoring
In all the studies, cellular DNA content from both controls and
fatty acid-treated samples was determined using Hoescht 33258
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Figure 7 Effects of fatty acids on nm-23 mRNA levels in HT1 15 cells
determined by Northern blotting. The experimental conditions were as in
Figure 1. Top, nm-23 probed mRNA; bottom, changes in nm23 mRNA level in
fatty acid treated vs control with loading errors corrected by j-actin signals.
Shown in the figure are ratios calculated as (nm23 signal in treated
cells/nm23 signal in control)/(actin signal in treated cells/actin signal in
control). Increased nm-23 mRNA was seen after GLA treatment of the cell
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Figure 8 Effects of GLA at different concentrations on nm-23 mRNA levels
in HT1 15 cells determined by Northern blotting. Cells were treated with GLA
for 24 h. Top, nm-23 probed mRNA; bottom, changes in nm23 mRNA level.
Shown are ratios of the changes with loading errors corrected by ,B-actin
signals (as in Figure 7). GLA at concentrations higher than 10 liM showed a
stimulatory effect
(final concentration 1.0 ,ug ml-'; Jiang et al, 1995b) to assess fatty
acid cytotoxicity. Briefly, at the end of each experiment, the DNA
from control and fatty acid-treated cells was extracted with 0.1%
SDS for 60 min. To the cell lysate was added the fluorescent indi-
cator Hoescht 33258 (Sigma) (final concentration 1.0 jg ml-').
The fluorescence was monitored by a Wellfluo multiscanner
(Denly, Sussex, UK) at exitation 356 nm and emission 458 nm.
British Journal ofCancer (1998) 77(5), 731-738
Cip\?~ O\r,>dv
I II
_.
0 CancerResearch Campaign 1998Effect ofn-6polyunsaturated fattyacids on nm-23 735
A
u
E
o 1.0
0.5*
0.0S Control With GLA
Figure 9 Effect of GLA on the in vitro invasion of MDA MB 231 cells. A, Cells cultured with medium as control; B, cells treated with GLA at 50gM for 72 h;
C, cells treated with HGF/SF (20 ng ml-1 final concentration); D, cells treated with HGF/SF plus GLA at 50gM; E, invasion as determined by crystal violet assay
(details given in Materials and methods). Shown are invasion indices obtained from the spectrophotometer. MDA MB 231 cells were invasive even without any
stimulation (A). This invasion was enhanced when HGF/SF was included (C). Inclusion of GLA in the culture system reduced both spontaneous and HGF/SF-
stimulated invasiveness (B and D). E, GLA significantly reduced the in vitro invasion, particularly that induced by HGF/SF. *P< 0.05 vs cell with medium alone;
**P < 0.05 vs cells with HGF/SF alone
RESULTS
Expression of nm-23-H1 in tumour cells
To confirm the expression ofnm-23 in the cells used, Northern and
Western blotting, together with immunocytochemistry, were
carried out. Western blotting showed a single band of protein at
approximately 18 kDa recognized by anti-nm-23-H1 antibody.
Northern blotting revealed an approximate 1-kb transcript in both
cell types. Immunocytochemistry confirmed that the staining of
nm-23-HI was located in the cytosolic region ofboth cells.
Effects of fatty acids on nm-23expression
We then tested the effect ofa range offatty acids on nm-23 protein
expression. Total cellular protein was prepared from each sample
for Western blotting. Ofall the fatty acids tested, gamma linolenic
acid and its lithium salt showed an up-regulatory effect on the nm-
23 protein level in both cell types (Figure 1, HT115 cells; Figure 2,
MDA MB 231 cells). In contrast, linoleic acid (LA) and arachi-
donic acid showed slight inhibitory effects. EPA had little effect.
This GLA-induced increase in nm23 expression was also
confirmed by immunocytochemistry (Figure 3).
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Concentration-dependent effects of GLA on nm-23
expression
GLA was then tested over a range of concentrations (1-150 JM).
The effect of GLA on the expression of nm-23 was seen from
10gM (Figure 4, HT115; Figure 5, MDA MB 231 cells), with a
maximal effect occurring at approximately 50gM. A concentration
of 50gM was chosen for a time course study ranging from 4 to
72 h. The maximum increase ofprotein was seen 12 h after initial
exposure (Figure 6).
Regulation of nm-23 mRNA by fatty acids
Northern blotting studies showed that nm-23 mRNA was selec-
tively increased in response to GLA and LiGLA (Figure 7). This
was also seen in a concentration-dependent manner (Figure 8).
The time course and concentration response were further deter-
mined and quantified with a slot blot, which revealed that the nm-
23 levels were seen to increase 4 h after treatment but returned to
near starting levels after 48 h. This time course indicated that the
regulation ofnm-23 expression by fatty acids was occurring at the
transcription level.
The role of GLA on tumour cell in vitro invasion
Using an in vitro invasion model, we then tested the effect ofGLA
on cell invasion of an extracellular matrix, Matrigel. At non-toxic
concentrations, GLA inhibited both spontaneous and hepatocyte
growth factor/scatter factor (HGF/SF)-induced cell invasion
(Figure 9). Both cell types showed a similar response to GLA.
Measurement of fatty acid cytotoxicity
In order to determine whether the observed effects arising after
fatty acid treatment were attributed to cytotoxicity, cell growth
was monitored using a Hoescht 33258 DNA assay. At the fatty
acid concentrations used in this study, the cellular DNA content
was not affected.
DISCUSSION
In this paper, we have shown that the polyunsaturated fatty acid
gamma linolenic acid selectively up-regulates the expression of
the metastasis-suppressor gene nm-23 in cells that are highly
invasive. This effect was not due to fatty acid cytotoxicity.
GLA and other fatty acids have been shown to be toxic to a range
ofhuman tumourcells, an effect that is thought to result in part from
the fatty acid-induced production of superoxide within the cell
(Horrobin, 1990). At lower concentrations, GLA and related fatty
acids may be involved in the regulation ofthe motility and invasive
behaviour ofcancer cells, and we have recently shown that GLA is
capable ofinhibiting both spontaneous and motogen-stimulated cell
motility and invasion in vitro (Jiang et al, 1995a, 1996, 1997a).
Previous studies have suggested that this is likely to be partly the
result of up-regulation of the cell-surface adhesion molecule E-
cadherin and desmosomal cadherin (desmoglein), which are recog-
nized metastasis-suppressor molecules (Jiang et al, 1995a and b,
1997b). However, such inhibition also occurred in cells that were
shown to be E-cadherin negative by Western blotting (e.g. HTl15
and MDA MB 231 cells), suggesting that GLA exerts its
invasion/motility inhibitory effects via an E-cadherin-independent
mechanism. The data reported here clearly show that GLA regulates
the expression of nm-23, and this correlates with a decreased inva-
sive potential ofthese tumour cells. We propose, therefore, that nm-
23 regulation may represent another pathway by which GLA can
inhibit cellular motility and invasion.
This study also shows that arachidonic acid (AA) reduced the
expression of nm-23. It has previously been shown that one of the
arachidonic acid metabolites, prostaglandin E2 (PGE2), also
suppresses nm-23 expression (Parhar et al, 1995). This indicates
that gamma linolenic acid exerts different effects compared with
some ofits other metabolites (i.e. AA and PGE2).
Diverse effects on cell behaviour are also seen with other
arachinonic acid metabolites. Prostacyclin has been shown to exert
an anti-metastatic effect, possibly by regulation of tumour-related
aggregation (Schneider et al, 1994). In contrast, 12(s)-HETE has
been reported to be pro-invasive and pro-metastatic by influencing
cell motility and invasion (Honn et al, 1992, 1994). Furthermore,
prostacyclin antagonizes the effect of 12(S)-HETE (Schneider et
al, 1994). While these effects by prostacyclin and 12(S)-HETE are
mediated by theirreceptors, the mechanisms ofthe effects ofGLA
and other EFAs are less clear as no receptors have been identified
for these fatty acids.
Work by Howlett et al (1994) has shown that nm-23 exerts a
novel function in breast cancer cells by inducing matrix deposition
and therefore basement membrane formation and growth arrest.
Although our study does not provide data on matrix deposition, we
have shown a strong correlation between the increased expression
of nm-23 and reduction of basement membrane invasion by these
cells, an effect consistent with the work ofHowlett et al (1994).
The serine phosphorylation of nm-23 correlates with reduced
metastatic activity oftumour cells (Macdonald et al, 1993) and, in
future studies, it will be useful to determine whether GLA is able
to promote such phosphorylation.
The data presented here may have clinical relevance. Patients
receiving GLA as acomponent ofa treatment regimen may benefit
from the effect on nm-23 seen in vitro. In some but not all studies
performed in both humans and animals bearing breast or liver
tumours, n-6 PUFAs have been shown to have beneficial effects
(Karmali et al, 1985; Ramchurren et al, 1985; McIllmurray and
Turkie, 1987; Van der Merwe et al, 1988, 1990; Pritchard and
Mansel, 1990). In recent studies, intravenous delivery of gamma
linolenic acid to patients with advanced pancreatic cancer showed
improvement in patients survival (Fearon et al, 1996), as did the
local application ofGLA into the brain in patients with malignant
glioma (Das et al, 1995).
In summary, this study shows that polyunsaturated fatty acids
are able to regulate the expression ofnm-23 in human cancer cells.
Such regulation is likely to be at the transcription level. Up-regula-
tion of metastasis-suppressor genes, such as nm-23, may prove
useful in the treatment ofcancer patients.
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